New arrangements for MHRA Good Practice inspections due to coronavirus

Friday, 20 March 2020 17:21

From: Medicines and Healthcare products Regulatory Agency As part of our response to the coronavirus outbreak, we have decided to conduct only essential Good Practice (GxP) inspections of Laboratories, Clinical Trials, Manufacturing,...Request free trial